Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Akari Therapeutics PLC

AKTX
Current price
1.17 USD +0.056 USD (+5.06%)
Last closed 1.21 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 9 746 151 USD
Yield for 12 month +455.33 %
1Y
3Y
5Y
10Y
15Y
AKTX
21.11.2021 - 28.11.2021

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid, as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration. The company is based in London, the United Kingdom. Address: 75/76 Wimpole Street, London, United Kingdom, W1G 9RT

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

80 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-4 000 USD

Last Year

-3 708 USD

Current Quarter

Last Quarter

Key Figures AKTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 802 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -115.51 %
PEG Ratio
Return On Equity TTM -1281.43 %
Wall Street Target Price 80 USD
Revenue TTM
Book Value -0.035 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.04 USD
Diluted Eps TTM -2.04 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AKTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AKTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 17.08.2023
Dividend Date

Stock Valuation AKTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.3418
Price Book MRQ 3.0692

Financials AKTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AKTX

For 52 weeks

1.1 USD 5.5 USD
50 Day MA 2.05 USD
Shares Short Prior Month 5 949
200 Day MA 3.11 USD
Short Ratio 0.76
Shares Short 10 516
Short Percent 0.19 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics